 |
인쇄하기
취소
|
Choong-wae completes Phase 2 trial of avanafil
Choong-wae Pharm says its has recently completed Phase 2 study of avanafil, Japan Tanabe’s phosphodiesterase type 5, or PDE5, inhibitor product candidate for the treatment of erectile dysfunction.
The trial took nine months from January in eight university hospitals, including Seoul National University Hospital, Korea University Hospital and Pusan University Hospital.
Choong-wae reported ...
The trial took nine months from January in eight university hospitals, including Seoul National University Hospital, Korea University Hospital and Pusan University Hospital.
Choong-wae reported ...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.